A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
NCT04261270
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
2019-nCoV Pneumonia
Interventions
DRUG:
ASC09F+Oseltamivir
DRUG:
Ritonavir+Oseltamivir
DRUG:
Oseltamivir
Sponsor
Tongji Hospital